Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Allogene Therapeutics, Inc. | Director | Common Stock | 1.87M | $5.41M | $2.90 | May 16, 2024 | Direct |
Allogene Therapeutics, Inc. | Director | Common Stock | 1.72M | $5M | $2.90 | May 16, 2024 | Indirect |
Ginkgo Bioworks Holdings, Inc. | Director | Class A Common Stock | 500K | $275K | $0.55 | Jun 12, 2024 | By Bellco Legacy LLC |
Ginkgo Bioworks Holdings, Inc. | Director | Restricted Stock Units | 433K | $238K | $0.55 | Jun 13, 2024 | Direct |
Ginkgo Bioworks Holdings, Inc. | Director | Class A Common Stock | 195K | $107K | $0.55 | Jun 12, 2024 | Direct |
Allogene Therapeutics, Inc. | Director | Stock Option (Right to buy) | 749K | Jan 25, 2024 | Direct | ||
Ginkgo Bioworks Holdings, Inc. | Director | Stock Option | 571K | Jun 13, 2024 | Direct | ||
Kronos Bio, Inc. | Director | Stock Option (Right to Buy) | 34K | Jun 25, 2024 | Direct | ||
UroGen Pharma Ltd. | Director | Stock Option (right ot buy) | 10K | Aug 6, 2024 | Direct |